| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCSER1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | C12orf75 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | BTBD7 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | METTL11B | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | APOOL | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | DENND4C | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | PQLC2L | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | C4orf19 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | CPXM2 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | IFITM3 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.07 |
